Show simple item record

dc.contributor.authorNeels, Leo
dc.contributor.authorVan Dyck, Walter
dc.date.accessioned2017-12-02T15:00:08Z
dc.date.available2017-12-02T15:00:08Z
dc.date.issued2016
dc.identifier.urihttp://hdl.handle.net/20.500.12127/5600
dc.description.abstractPharma has struggled with the dilemma of drug pricing and patent enforcement in developing countries for decades. In an ideal world, everyone has access to quality health services without financial hardship, but, in the real world, not every country has a strong, efficient and well-run health system. In the past, pharmaceutical companies have been named and shamed for focusing on the richer countries that can afford to pay the prices needed to recoup high R&D costs – but things may be changing.
dc.language.isoen
dc.subjectOperations & Supply Chain Management
dc.titleThe price of success? Pharmaceutical IP and global healthcare: a positive alliance
dc.identifier.journalPharma Times Magazine
dc.source.issueMay
dc.source.beginpage16
dc.source.endpage17
vlerick.knowledgedomainOperations & Supply Chain Management
vlerick.knowledgedomainSpecial Industries : Healthcare Management
vlerick.supervisor
vlerick.typearticleArticle in professionally oriented journal - other
vlerick.vlerickdepartmentTOM
dc.identifier.vperid165113
dc.identifier.vperid31183
dc.identifier.vpubid6894


This item appears in the following Collection(s)

Show simple item record